A hybridization-ligation PCR assay was developed for the simultaneous detection and identification of 21 pneumococcal serotypes and 8 pairs of serotypes in the same serogroup: 1, 2, 3, 4, 5, 6A, 6B, 6C-6D, 7F-7A, 8, 9A-9V, 9N-9L, 11A, 14, 15B-15C, 16F,  17F, 18B-18C, 19A, 19F, 20, 21, 22A-22F, 23A, 23B, 23F, 28A-28F, 35B and 38 . This novel assay was validated with 185 serotyped pneumococcal invasive clinical isolates and 57 culture-negative pleural fluids previously typed by real-time PCR.
We designed common primers from sequences of the Prunus necrotic ringspot virus cp gene, isolate AprIt.caf1 (GenBank no. AJ133199.1), as follows: forward primer (5=-3=), GCTGGTGGAT GCCGTTCTTG (nucleotides 71 to 90); reverse primer (5=-3=), CTCCATTCGGATGGCACTTCTTG (nucleotides 91 to 113).
DNA was extracted with a QIAamp DNA minikit (Qiagen, Hilden, Germany). The Nanodrop method (Nanodrop Technologies, Wilmington, DE) was used to determine DNA concentrations and detection limits (Fig. 1, panel I) . The assay was performed in a DNA Engine Dyad thermal cycler (Bio-Rad Laboratories, Hercules, CA) and involved three stages, as follows. (i) Hybridization was performed at 95°C for 1 min followed by 60°C for 16 h with 5 l of DNA template (10 to 75 ng), which had been denatured at 98°C for 5 min and cooled to 25°C, and hybridization master mix, which contained 1.5 l of hybridization buffer (PerfectHyb Plus hybridization buffer; 1ϫ; Sigma-Genosys, Madrid, Spain) and 1.5 l of all half probes (0.01 M concentration of each probe). (ii) Ligation was performed for 15 min at 54°C using 0.5 U of thermostable ligase (Taq DNA ligase; New England Biolabs), followed by 5 min at 98°C, and then the sample was held at 4°C. (iii) PCR was performed with 5 l of ligation product, 0.2 M concentrations of forward and reverse primers, and Illustra Puretaq Ready-To-Go PCR beads (GE Healthcare, Little Chalfont, United Kingdom). The thermocycling profile was as follows: 35 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 1 min, followed by 72°C for 20 min and cooling at 4°C. PCR products were analyzed using a QIAxcel multicapillary gel electrophoresis system (Qiagen, Hilden, Germany). All samples were unambiguously assigned according to their predicted molecular weight ( From the 29 probes designed to target specific serotypes, 21 were completely specific for the targeted serotype: 1, 2, 3, 4, 5, 6A, 6B, 8, 10A, 14, 16F, 17F, 19A, 19F, 20, 21, 23A, 23B, 23F, 35B, and 38. Eight probes identified pairs of serotypes of the same sero-group: 6C-6D, 7A-7F, 9A-9V, 9N-9L, 15B-15C, 18B-18C, 22A-22F and 28A-28F. The high specificity of probes was demonstrated by the fact that all clinical isolates were correctly typed and no nonpneumococcal isolates hybridized with any pneumococcal probe. A control for Streptococcus pneumoniae detection was included in the study (Fig. 1, panel I) .
PCR products were sequenced in a 3730XL sequencer using a BigDye Terminator cycle sequencing kit, v3.1 (Applied Biosystems, Foster City, CA). The resulting sequences exactly matched the corresponding published sequences. The lower detection limit of this method was 5 ng, corresponding to 25 bacteria (Fig. 1,  panel I ). Homemade molecular weight markers were created with a mixture of all serotype-specific amplification products (Fig. 2,  panel II) .
In order to assess the usefulness of the assay in culture-negative clinical samples, 57 previously studied PFs from children diagnosed with PE were tested (8, 13) . The results are shown in Fig. 2 , panel I, and the supplemental material. Compared with the study by Obando et al. (8) , the most relevant finding was the identification of a serotype for seven samples of 21 previously unidentified serotypes. Furthermore, all serotypes of serogroup 9 were detected in two independent reactions: 9A-9V and 9N-9L. Serotypes responsible for PE were fully covered by the assay (7). The sensitivity of the assay was sufficient to allow it to be used directly on clinical samples but was lower than that noted with real-time PCR (13) . This could be because the PE samples were repeatedly frozen and thawed as a consequence of having been used in a previous study. However, this is compensated for by its overall capacity as a 29-multiplexed assay in a single tube. To our knowledge, the method described here includes the largest number of pneumococcal se- rotypes detected in a single assay, comprising about 95% and 80% of the IPD serotypes in Spain and worldwide, respectively. Therefore, the assay could be useful in colonization studies in which cocolonization with some pneumococcal serotypes is common. Furthermore, this novel assay is highly reproducible. It is also reasonably cost-effective, because only a thermocycler and electrophoresis equipment are needed. This means that it could easily be introduced into most clinical laboratories.
